Medical World News® After Hours: Elizabeth Comen, MD, Discusses How Dance Helps Her Unplug Plus Connect With Patients

Video

Elizabeth Comen, MD, discusses how she balances her love of dance with both her family and her career as a breast cancer oncologist.

When Elizabeth Comen, MD, isn’t busy treating patients with breast cancer at Memorial Sloan Kettering Cancer Center, she is exploring her passion for dance, ranging from hip hop to jazz.

She started dancing from a young age with ballet and jazz but fell in love with the freedom of movement that hip hop allowed her. She even likes to dance with her patients in the chemotherapy suite before they start their treatment to get their spirits up. She explains how she uses dance to help patients with breast cancer reconnect with their femininity and sexuality.

CancerNetwork® sat down with Comen to discuss how she balances her love of dance with both her family and her career as a breast cancer oncologist.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.

Recent Videos
Collaboration among different medical and research institutions may help improve quality of care for patients with cancer exposed to climate disasters.
Given resource scarcity, developing practice strategies for resource-constrained settings would require aid from commercial and government stakeholders.
According to Megan Mullins, PhD, MPH, challenging cultural norms surrounding death and dying may reduce the receipt of low-value end-of-life cancer care.
Earlier and more frequent talks about disabling ICDs with patients receiving end-of-life care and their families may help avoid excessive pain.
Large international meetings may facilitate conversations regarding disparities of care outside of high-income countries.
AI-powered tools may help alleviate doctor burnout and give clinicians more time to directly engage with patients.
Artificial intelligence may have the potential to enrich pathology practices to help identify aspects of tumor biology not seen with the human eye.
Related Content